skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Positive modulator of bone morphogenic protein-2

Abstract

Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.

Inventors:
; ; ;
Issue Date:
Research Org.:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1650734
Patent Number(s):
10611810
Application Number:
12/023,801
Assignee:
Ferring International Center S.A. (CH)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
DOE Contract Number:  
AC02-98CH10886
Resource Type:
Patent
Resource Relation:
Patent File Date: 01/31/2008
Country of Publication:
United States
Language:
English

Citation Formats

Zamora, Paul O., Pena, Louis A., Lin, Xinhua, and Takahashi, Kazuyuki. Positive modulator of bone morphogenic protein-2. United States: N. p., 2020. Web.
Zamora, Paul O., Pena, Louis A., Lin, Xinhua, & Takahashi, Kazuyuki. Positive modulator of bone morphogenic protein-2. United States.
Zamora, Paul O., Pena, Louis A., Lin, Xinhua, and Takahashi, Kazuyuki. Tue . "Positive modulator of bone morphogenic protein-2". United States. https://www.osti.gov/servlets/purl/1650734.
@article{osti_1650734,
title = {Positive modulator of bone morphogenic protein-2},
author = {Zamora, Paul O. and Pena, Louis A. and Lin, Xinhua and Takahashi, Kazuyuki},
abstractNote = {Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2020},
month = {4}
}

Patent:

Save / Share:

Works referenced in this record:

Laminin-derived multi-domain peptides
patent, October 2010


Interleukin-12 fusion protein
patent, November 1999


FGF growth factor analogs
patent, July 2012


Method for making biocompatible medical article
patent, July 2001


Process for preparing biologically compatible polymers and their use in medical devices
patent, August 1999


Fanphiregulins: a family of heparin-binding epithelial cell growth factors
patent, November 1998


Growth factor analogs
patent, August 2008


Human basic fibroblast growth factor analog
patent, September 2001


Method and apparatus for occlusion and reinforcement of aneurysms
patent, January 2001


Platelet derived growth factor agonists
patent, July 1994


Peptide compounds useful for modulating FGF receptor activity
patent, April 2001


Amphipathic coating for modulating cellular adhesion composition and methods
patent, January 2002


Expanded polytetrafluoroethylene vascular graft with coating
patent, April 2002


Peptides and compounds that bind to a receptor
patent, June 2001


Implantable medical device
patent, August 2001


Chimeric proteins
patent, January 2001


Hydrogel for the therapeutic treatment of aneurysms
patent, September 2000


Cross-linked polymer compositions and methods for their use
patent, March 2003


Process of degrading and regenerating bone and tooth material and products
patent, October 1979


Synthetic peptides having FGF receptor affinity
patent, April 2003


Composite shaped bodies and methods for their production and use
patent, March 2005


Multivalent ligands which modulate angiogenesis
patent, September 2000


Ligand-binding, dimerized polypeptide fusions
patent, November 2001


Peptides that bind IL-2 receptors
patent, June 1997


Stents with hybrid coating for medical devices
patent, May 2001


Three dimensional, low friction vasoocclusive coil, and method of manufacture
patent, October 2003


Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
patent, July 1997


Branched synthetic peptide conjugate
patent, October 1997


Peptides and compounds that bind to the IL-1 receptor
patent, January 1999


Three dimensional, low friction vasoocclusive coil, and method of manufacture
patent, January 2001


Peptides and compounds that bind to the IL-1 receptor
patent, March 1997


Methods of administering peptides that bind to the erythropoietin receptor
patent, November 1998


Drug coating with topcoat
patent, August 2000


Non-thrombogenic and anti-thrombogenic polymers
patent, June 2002


Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
patent, October 2002


Shape memory segmented detachable coil
patent, April 2003


Compositions and methods for treating diverticular disease
patent, July 2007


Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors
patent, February 2000


Variable stiffness coil for vasoocclusive devices
patent, May 2002


Implantable device having substances impregnated therein and a method of impregnating the same
patent, July 2003


Circularly permuted ligands and circularly permuted chimeric molecules
patent, January 2000


Method for forming impregnated synthetic vascular grafts
patent, June 1989


N-terminal modifications of RANTES and methods of use
patent, January 2001


Shape memory segmented detachable coil
patent, April 2001


Tubular expanded polytetrafluoroethylene implantable prostheses
patent, September 1997


Chimeric hepatocyte growth factor (HGF) ligand variants
patent, November 1997


Medical device with biomolecule-coated surface graft matrix
patent, February 1999


Methods of modulating tissue growth and regeneration
patent, May 1999


Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
patent, August 1999


Fibroblast growth factor conjugates
patent, October 1997


Synthetic heparin-binding factor analogs
patent, April 2010


Peptides and compounds that bind to the IL-1 receptor
patent, June 1998


Positive modulator of bone morphogenic protein-2
patent, January 2009


Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
patent, September 2001


PDGF-B analogues
patent, April 1996


Peptides and compounds that bind to the IL-1 receptor
patent, March 1999


Compositions for coating microcapsules and other surfaces
patent, May 2001


System for assaying binding to a heparin-binding growth factor receptor
patent, August 1998


Medical device with lubricious coating
patent, April 1996


Dual chain synthetic heparin-binding growth factor analogs
patent, October 2009


Peptides and compounds that bind to the IL-5 receptor
patent, September 1997


Platelet-derived growth factor analogues
patent, February 2002


Biodegradable elastomer and method of preparing same
patent, January 2006


Non-thrombogenic and anti-thrombogenic polymers
patent, August 2000


Single branch heparin-binding growth factor analogs
patent, January 2012


Crosslinkable macromers
patent, June 2002


Product display rack
patent, March 2005


Peptides and compounds that bind to a receptor
patent, February 1999


Stabilized FGF composition
patent, April 1993


Vascular grafts
patent, May 1988


Vasoocclusive coil
patent, October 2000


Bioactive coating composition and methods
patent, July 2005


Heterodimeric chain synthetic heparin-binding growth factor analogs
patent, May 2009


Synthetic heparin-binding growth factor analogs
patent, January 2007


Peptides and compounds that bind to ELAM-1
patent, July 1997


Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
patent, September 2002


Osteogenic devices
patent-application, December 2003


Inductive collagen based bone repair preparations
patent, January 1986


Intravascular flow modifier and reinforcement device
patent, December 2003


Fusion glycoproteins
patent, September 1999


Medical device coated with interpenetrating network of hydrogel polymers
patent, September 2000


Glycosaminoglycan-synthetic polymer conjugates
patent, April 1996


Polyvalent peptide pharmaceutical applications
patent, June 1998


Compounds and peptides that bind to the erythropoietin receptor
patent, June 1998


Crosslinked polymer compositions and methods for their use
patent, April 2000


Polyoxime compounds and their preparation
patent, April 2001


Intravascular device push wire delivery system
patent, August 2000


Non-thrombogenic coating composition and methods for using same
patent, September 1999


Multivalent ligands which modulate angiogenesis
patent, May 2001


Implant fixation
patent, April 1992


Variable stiffness coil for vasoocclusive devices
patent, December 2003


Matrix-free osteogenic devices, implants and methods of use thereof
patent, July 2002


Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
patent, March 1998


Porous β-tricalcium phosphate granules for regeneration of bone tissue
patent, September 2005


Formulations and methods for delivery of growth factor analogs
patent, March 2010


Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1
patent, July 1998


Nucleic acid coating compositions and methods
patent, July 2003


Hetero-polyoxime compounds and their preparation by parallel assembly
patent, December 1999


In situ polymerizable hydrogels
patent, November 2004


Composite structure vascular prostheses
patent, March 1980


Vasoocclusive coil
patent, October 2001


Universal biocompatible coating platform for medical devices
patent, October 2001


Cross-linked heparin coatings and methods
patent, December 2008


Silyl and Heparin compositions
patent, October 2003


Vasoocclusive device for treatment of aneurysms
patent, September 2003


Dual chain synthetic heparin-binding growth factor analogs
patent, April 2012


FGF homologs
patent, November 1999


Intravascular flow modifier and reinforcement device
patent, December 2000


Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
patent, October 1997


Absorbable brachytherapy and chemotherapy delivery devices and methods
patent, June 2001


Implant coating for control of tissue/implant interactions
patent, December 2002


Positive modulator of bone morphogenic protein-2
patent, June 2017


Fusion polypeptides and proteins
patent, October 1996


Peptides and compounds that bind to the IL-5 receptor
patent, August 1997


Peptides and compounds that bind to the IL-1 receptor
patent, July 1998


Drug delivery collagen-impregnated synthetic vascular graft
patent, March 1993